1. Direct comparison of the immunogenicity of major histocompatibility complex-I and -II deficient mesenchymal stem cells in vivo
   Darius Halm et al, 2021, Biological Chemistry CrossRef
2. Distinct Responsiveness of Tumor-Associated Macrophages to Immunotherapy of Tumors with Different Mechanisms of Major Histocompatibility Complex Class I Downregulation
   Adrianna Piatakova et al, 2021, Cancers CrossRef
3. Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients
   Francesco Sabbatino et al, 2020, International Journal of Molecular Sciences CrossRef
4. Classification of ovarian cancer associated with BRCA1 mutations, immune checkpoints, and tumor microenvironment based on immunogenomic profiling
   Yousheng Wei et al, 2020, PeerJ CrossRef
5. The Present and Future of Virology in the Czech Republic—A New Phoenix Made of Ashes?
   Tomas Ruml, 2022, Viruses CrossRef
6. Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy
   Lichen Zhu et al, 2020, Journal of Immunology Research CrossRef